Adherium December 2019 Update Presentation
Filed with ASX · · 25 pages · English
Adherium Limited ACN 605 352 510 (Adherium or the Company), (ASX code: ADR) provides the attached Company update presentation supporting the Rights Issue offer announced 11 December 2019. The release of this announcement was authorised by the Board of Adherium. Rob Turnbull Joint Company Secretary INTRODUCTORY SUMMARY A Digital Health Company focused on Medication Adherence, with the market leadin
In the deck
Story so far
Earlier from Adherium
- Adherium Non-renounceable Rights Issue Offer Document
- Adherium announces Non-Renounceable Issue
- Adherium appoints Peter Stratford CEO and Mike Motion CCO
- Adherium and Patients Know Best strategic collaboration
- Amended - Adherium announces $1.1m notes financing
Later from Adherium
- Adherium Completes $5.4m Capital Raise
- Adherium announces collaboration with HGE Health in COPD
- Adherium and Planet Innovation partner in tech development
- Adherium appoints Mike Motion CEO/Director and Anne Bell CFO
- Adherium progresses US sales agreement with Monaghan Medical
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium